Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,261 | -5,540 | -4,121 | -2,546 | -428 |
| Depreciation Amortization | 40 | 97 | 73 | 49 | 23 |
| Accounts receivable | -475 | -207 | -808 | -94 | -102 |
| Accounts payable and accrued liabilities | -238 | 173 | -673 | -658 | N/A |
| Other Working Capital | -778 | -1,008 | -1,972 | -1,352 | -717 |
| Other Operating Activity | 1,323 | 3,538 | 3,739 | 2,191 | 541 |
| Operating Cash Flow | $-1,389 | $-2,946 | $-3,762 | $-2,410 | $-681 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -5,550 | N/A |
| PPE Investments | -5 | -68 | -48 | -42 | -2 |
| Purchase Of Investment | -165 | N/A | N/A | N/A | -68 |
| Purchase Sale Intangibles | -14 | -10 | -2 | N/A | N/A |
| Other Investing Activity | 36 | -3,660 | -2,680 | -1,431 | -385 |
| Investing Cash Flow | $-134 | $-3,727 | $-2,728 | $-7,023 | $-455 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 13 | 13 | N/A |
| Other Financing Activity | 0 | 500 | 500 | 500 | 100 |
| Financing Cash Flow | $N/A | $500 | $513 | $513 | $100 |
| Beginning Cash Position | 4,194 | 10,368 | 10,368 | 10,368 | 10,368 |
| End Cash Position | 2,672 | 4,194 | 4,391 | 1,447 | 9,331 |
| Net Cash Flow | $-1,523 | $-6,174 | $-5,977 | $-8,921 | $-1,037 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,389 | -2,946 | -3,762 | -2,410 | -681 |
| Capital Expenditure | -5 | -68 | -48 | -42 | -2 |
| Free Cash Flow | -1,394 | -3,014 | -3,810 | -2,453 | -684 |